BioDelivery Sciences International (BDSI)
Create an AlertBioDelivery Sciences International Gross Profit Margin Quarterly:
76.88% for March 31, 2013BioDelivery Sciences International Historical Gross Profit Margin Quarterly Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 76.88% |
| Dec. 31, 2012 | 96.05% |
| Sept. 30, 2012 | 80.00% |
| June 30, 2012 | 97.70% |
| March 31, 2012 | 97.73% |
| Dec. 31, 2011 | -14.09% |
| Sept. 30, 2011 | 43.42% |
| June 30, 2011 | |
| March 31, 2011 | -29.62% |
| Dec. 31, 2010 | 98.55% |
| Sept. 30, 2010 | 91.03% |
| June 30, 2010 | 64.06% |
| March 31, 2010 | 94.53% |
| Dec. 31, 2009 | 96.75% |
About Gross Profit Margin
A gross profit margin is the difference between sales and the cost of goods sold divided by revenue. This represents the percentage of each dollar of a company's revenue available after accounting for cost of goods sold.
If a company produces phones and earns $32 million in sales but pays $24 million for the items sold, then the company's gross profit margin would be ($32M - $24M) / $32M = 25 percent.
Cutting costs result in higher gross profit margins. If a company sells phones for 500 dollars and the cost of the producing the phone is $250, the current gross profit margin is 50 percent ((500-250)/500). If the company is able to reduce production costs from $250 to $200, the gross profit margin is 60 percent ((500-200)/500).
Note : Profit margins are very dependent on sector. Companies that sell bland potato chips may not have very high margins, but will sell a sizable quantity of potato chips. A company that sells consulting services will likely have higher profit margins, but sell lower quantities.
Learn More
BDSI Gross Profit Margin Quarterly Benchmarks
| Companies | |
|---|---|
| Cempra | |
| AMAG Pharmaceuticals | 83.55% |
| Chelsea Therapeutics International |
BDSI Gross Profit Margin Quarterly Rankings
| Overall |
96th percentile 634 of 16782 |
| Sector |
90th percentile 128 of 1410 in Healthcare |
| Industry |
87th percentile 57 of 454 in Biotechnology |
BDSI Gross Profit Margin Quarterly Range, Past 5 Years
| Minimum | -29.62% | Mar 2011 |
| Maximum | 98.55% | Dec 2010 |
| Average | 68.69% |